Pharmacy

Amantadine Generic Symadine

Home » Prescription Drugs 1 » Amantadine Generic Symadine

USFDA Approved Medicine for the treatment of Influenzavirus A[2][3][4][5] in adults and to help reduce symptoms of Parkinson's disease and drug-induced extrapyramidal syndromes.Prevention and treatment of signs and symptoms of infection caused by various strains of influenza A virusAmantadine is effective in the treatment of active influenza A infection when administered within 48 hours after the onset of symptoms.Treatment of Parkinson's diseaseIdiopathic parkinsonism Secondary parkinsonism (e.g. of post-encephalitic type of cerebrovascular origin or drug-induced parkinsonism) (see Interaction with other medicinal products and other forms of interaction). Amantadine can be given alone for initial therapy or combined with anticholinergic drugs or L-dopa.

Buy Amantadine Generic Symadine and other Prescription Drugs 1 products online at Medstore.

Buy Online at Medstore - Click Here!

About Amantadine Generic Symadine:

Product Type: Prescription Drugs 1

Amantadine ( Generic Symadine Symmetrel )

Amantadine (Generic Symadine Symmetrel)

Generic Symadine Symmetrel

100mg 100 Capsules 200(2 x 100) Caps 400(4 x 100) Caps Generic Symadine Symmetrel Amantadine

View more Prescription Drugs 1

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.